Matrix Capital Management Company, LP 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-11-09 4:34 pm Purchase |
2023-11-09 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 6,922,870 14.100% |
1,560,000![]() (+29.09%) |
Filing |
2022-12-07 4:30 pm Purchase |
2022-12-05 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 5,362,870 14.500% |
1,250,000![]() (+30.39%) |
Filing |
2021-11-04 4:58 pm Purchase |
2021-11-02 | 13D | Aura Biosciences, Inc. AURA |
Matrix Capital Management Company, LP | 4,112,870 14.480% |
4,112,870![]() (New Position) |
Filing |